ADHD Trial, Recruiting (NCT06725186)

ADHD Trial, Recruiting NCT06725186 Sponsor: Virginia Polytechnic Institute and State University Condition: ADHD

Printed from Voxsanity (voxsanity.com.au) — NCT06725186 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Adhd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The child has a diagnosis of ADHD and is currently in middle school or high school.
The child has a verbal IQ score of 80 or above, as measured by a standard intelligence test called the Wechsler Intelligence Scale for Children, Fifth Edition.
The child does not have a severe developmental delay caused by genetic conditions (such as Down Syndrome) or complications during pregnancy or birth (such as infection or being born extremely prematurely).
The participating parent or legal guardian has legal custody of the child and is responsible for making medical decisions for them.
The family uses English as one of their main languages and is able to take part in study visits and the program, which are conducted in English.

Who may not be able to join:

The child does not have a confirmed ADHD diagnosis, either from previous records or from an assessment done as part of joining the study.
The child is outside the age range of 11 to 16 years old at the time of enrolling in the study.
The participating parent does not have legal custody of the child.
The parent or child is not fluent in English.
The child has a severe developmental delay caused by a genetic condition (such as Down Syndrome) or complications from pregnancy or birth (such as infection or being born extremely prematurely).
The child has an IQ score below 70.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Rosanna Breaux, PhD, Virginia Polytechnic Institute and State University

Phone: 5402318276

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06725186

Sponsor: Virginia Polytechnic Institute and State University

Phase: Not Applicable

Status: Recruiting

Condition: ADHD

Trial contact: 5402318276

More information: https://clinicaltrials.gov/study/NCT06725186

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The child has a diagnosis of ADHD and is currently in middle school or high school.
The child has a verbal IQ score of 80 or above, as measured by a standard intelligence test called the Wechsler Intelligence Scale for Children, Fifth Edition.
The child does not have a severe developmental delay caused by genetic conditions (such as Down Syndrome) or complications during pregnancy or birth (such as infection or being born extremely prematurely).
The participating parent or legal guardian has legal custody of the child and is responsible for making medical decisions for them.
The family uses English as one of their main languages and is able to take part in study visits and the program, which are conducted in English.

Who may not be able to join:

The child does not have a confirmed ADHD diagnosis, either from previous records or from an assessment done as part of joining the study.
The child is outside the age range of 11 to 16 years old at the time of enrolling in the study.
The participating parent does not have legal custody of the child.
The parent or child is not fluent in English.
The child has a severe developmental delay caused by a genetic condition (such as Down Syndrome) or complications from pregnancy or birth (such as infection or being born extremely prematurely).
The child has an IQ score below 70.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Virginia Polytechnic Institute and State University

Registry

ClinicalTrials.gov

Start date

15 January 2025

Est. completion

1 May 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Difficulties in Emotion Regulation Scale - Short Form (DERS-SF); Cognitive Emotion Regulation Questionnaire (CERQ); Observed Parent Emotion Socialization Strategies; Conflict Behavior Questionnaire (CBQ); Coping with Children's Negative Emotions Scale (CCNES) - Adolescent Version -

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov